We are an innovation network of 700+ teams and projects, driving breakthroughs in computing to push humanity forward.

Decentralized
The latest episode of the @juanbenet Podcast features @AdamMarblestone, CEO & co-founder of Convergent Research (@Convergent_FROs). Adam is a leading figure in shaping how ambitious science gets funded and built. In this conversation, he shares that a full mouse-brain connectome — once estimated at $10B — would cost roughly $100–200M today, and that a human one could follow for roughly $1–2B within several years' program: numbers that would have sounded fictional a decade ago. He pioneered the Focused Research Organization (FRO) model — time-bound teams built to produce the public goods that neither academia nor a startup will fund — which has since inspired the NSF's new $1.5B X-Labs initiative. This conversation is about what's next and what it takes to get there: what mapping a complete mammalian brain could unlock — insights into brain disease, consciousness, how the brain actually learns, and a path to mind uploading. "We badly need a circuit-mapping frontier lab," Adam says of connectomics — a field he calls one of the most neglected, and the one most poised to scale, in neuroscience today. Full conversation: piped.video/X0B_GWTuEFo
2
7
28
4,596
Protocol Labs retweeted
Yesterday @Bholden published the PL Capital Rails Computing Primitives Thesis. The core idea: crypto primitives aren't a vertical, they're much closer to math. Crypto proofs, FHE, TEEs, and tokens are complex tools with unusually wide reach. They future-proof the internet and the next generation of infrastructure. Building or investing here? Reach out 🫡
1
7
415
Protocol Labs retweeted
All of our patients until now have had age-related macular degeneration (AMD). I'm excited that we've implanted our first Stargardt's patient, the first of several new indications we are now bringing to the clinic. Our PRIMalia study is enrolling in Sydney!
Blind Stargardt patient reads letter again in PRIMA by Science clinical trial. Stargardt disease destroys central vision. There is no treatment that brings it back. This clinical trial patient was diagnosed with Stargardt disease and became legally blind – he could no longer read or recognize faces. He's now part of the clinical trial testing Science's PRIMA implant (approved in Europe for geographic atrophy) in patients with Stargardt disease and retinitis pigmentosa. During his first rehabilitation session after surgery, he saw a letter again.
11
18
161
15,778
Protocol Labs retweeted
Blind Stargardt patient reads letter again in PRIMA by Science clinical trial. Stargardt disease destroys central vision. There is no treatment that brings it back. This clinical trial patient was diagnosed with Stargardt disease and became legally blind – he could no longer read or recognize faces. He's now part of the clinical trial testing Science's PRIMA implant (approved in Europe for geographic atrophy) in patients with Stargardt disease and retinitis pigmentosa. During his first rehabilitation session after surgery, he saw a letter again.
1
16
63
18,255
Protocol Labs retweeted
Today we announce PL Capital Rails Computing Primitives Thesis. I've been proud to work with my partner @Bholden on investing around this & impressed by the clarity with which he expresses it here. The core idea: crypto primitives aren't a vertical, they're much closer to math. Crypto proofs, FHE, TEEs, and tokens show up wherever a system needs a guarantee it can't get any other way. From the outside, that can make a portfolio look scattered. From the inside, it's a concentrated bet on a small set of tools with unusually wide reach. Our filter is simple: if what you're building could be spun up with a simple database or a normal payments API, it's likely not for us. Instead, we're backing technically complex bets that leverage cryptography to future-proof the internet and the next generation of infrastructure. We believe AI agents, private compute, and the machine economy broadly mean the first generation of customers have finally arrived. If you're building here, reach out 🫡
3
6
23
1,673
A major milestone for @PrecisionNeuro_ as they build the clinical infrastructure to bring BCI to more patients. Learn more about Precision’s minimally invasive BCI and its path toward broader clinical use in Ben Rapoport's conversation with @juanbenet: bit.ly/3Ts1ace
Precision Neuroscience has closed an oversubscribed $250M Series D, co-led by @PershingSquare Capital Management, The Ackman Oxman Institute, and a leading life sciences investment fund. Total raised: ~$430M. But the financing is only part of the story. Precision now has completed 100+ procedures across 18 major medical institutions. Building BCI requires more than an interface. It requires clinical infrastructure. Since our last financing @PrecisionNeuro_ has also: - Received @FDA clearance for Layer 7™ - Expanded peer-review clinical research - Partnered with @Medtronic - Expanded U.S. MEMS manufacturing The next phase of BCI will be defined not only by what the technology can do in a laboratory. It will be defined by whether companies can build the clinical, regulatory, and manufacturing infrastructure required to bring it to patients. This funding will support: - Expanded clinical work - Additional FDA review - Commercialization infrastructure Read the full news release here: globenewswire.com/news-relea… @BillAckman @PershingSquare @BCapitalGroup, @ARKInvest, @MubadalaCapital, @MiraeAsset, @Hitachi Ventures. Precision’s brain-computer interface is an investigational device and is not available for sale in the United States.
2
1
8
3,233
Protocol Labs retweeted
Tremendous progress from @PrecisionNeuro_ : - An oversubscribed $250M Series D - Received @FDA clearance for Layer 7™ - Expanded peer-review clinical research - Partnered with @Medtronic - Expanded U.S. MEMS manufacturing Congrats to the team in accelerating a future where people can communicate, move, and live more independently!
Precision Neuroscience has closed an oversubscribed $250M Series D, co-led by @PershingSquare Capital Management, The Ackman Oxman Institute, and a leading life sciences investment fund. Total raised: ~$430M. But the financing is only part of the story. Precision now has completed 100+ procedures across 18 major medical institutions. Building BCI requires more than an interface. It requires clinical infrastructure. Since our last financing @PrecisionNeuro_ has also: - Received @FDA clearance for Layer 7™ - Expanded peer-review clinical research - Partnered with @Medtronic - Expanded U.S. MEMS manufacturing The next phase of BCI will be defined not only by what the technology can do in a laboratory. It will be defined by whether companies can build the clinical, regulatory, and manufacturing infrastructure required to bring it to patients. This funding will support: - Expanded clinical work - Additional FDA review - Commercialization infrastructure Read the full news release here: globenewswire.com/news-relea… @BillAckman @PershingSquare @BCapitalGroup, @ARKInvest, @MubadalaCapital, @MiraeAsset, @Hitachi Ventures. Precision’s brain-computer interface is an investigational device and is not available for sale in the United States.
1
2
8
56,514
Protocol Labs retweeted
Launchpad wallets can now be funded by credit card. Previously, funding a wallet meant buying elsewhere and transferring in. Card funding happens on the Launchpad itself, through @privy_io, and self-custody is unchanged: the wallet stays yours, and Bio never holds the funds. This is the first step toward something larger. Most people who want to fund science don't hold crypto and shouldn't have to. We're building the rails that let fiat capital reach research directly, and removing each piece of friction between wanting to back a project and doing it.
23
23
168
39,161
Infrastructure built from firsthand training constraints, now available for teams building at scale. A notable release from @PrimeIntellect for RL training.
Introducing Prime Sandboxes: MicroVM sandboxes purpose-built for RL training. Model training requires running tens of thousands of concurrent sandboxes, leading to complex and costly configuration. We built Prime Sandboxes for our own team. Today we're releasing them publicly.
1
8
2,544
.@PLCapital's @Bholden will join @AgenticZero at @Techweek_ to speak and connect with founders building with cryptographic and decentralized systems.
Replying to @Bholden
@bholden from @plcapital is joining Agentic Zero 🤝 Brad leads PLC Rails, backing early-stage founders building with cryptographic and decentralized systems. Excited to hear your take on the future of AI infrastructure and financial rails!
2
8
2,257
Terry, a Neuralink VOICE trial participant, trained a brain-to-voice decoder by miming speech, then just by thinking the words, and now hears them in his own voice. Amazing work by Terry and the Neuralink team on the VOICE trial. Moments like this are why we're so excited about accelerating the field of Neurotech at PL R&D piped.video/watch?v=_j806JHh…
2
1
5
579
Protocol Labs retweeted
Proud to be an early @okta XAA partner. Come say hi if you're at Oktane!
9
16
95
3,277